CN Patent

CN116650500B — 治疗癌症的方法

Assigned to Sanitary Material R&d Management Co ltd · Expires 2026-03-06 · 0y expired

What this patent protects

本发明涉及治疗癌症的方法，提供了治疗实体瘤、B细胞淋巴瘤、或具有异常H3‑K27甲基化的癌症的方法，该方法包括向对其有需要的受试者口服给予具有治疗有效量的EPZ‑6438的剂型。本发明涉及包含人类组蛋白甲基转移酶EZH2的一种或多种抑制剂的药物组合物，和使用这一种或多种EZH2抑制剂治疗癌症的方法。

USPTO Abstract

本发明涉及治疗癌症的方法，提供了治疗实体瘤、B细胞淋巴瘤、或具有异常H3‑K27甲基化的癌症的方法，该方法包括向对其有需要的受试者口服给予具有治疗有效量的EPZ‑6438的剂型。本发明涉及包含人类组蛋白甲基转移酶EZH2的一种或多种抑制剂的药物组合物，和使用这一种或多种EZH2抑制剂治疗癌症的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN116650500B
Jurisdiction
CN
Classification
—
Expires
2026-03-06
Drug substance claim
No
Drug product claim
No
Assignee
Sanitary Material R&d Management Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.